Latvia vs Oman: Treatment success rate for patients treated for MDR-TB
Latvia
0.0%
in 2022
Oman
0.0%
in 2022
Latvia rank
159th
Oman rank
159th
Treatment success rate for patients treated for MDR-TB over time
- Latvia
- Oman
How they compare
Latvia currently reports 0.0% against 0.0% in Oman, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2006 it was Latvia ahead.
Latvia ranks 159th and Oman ranks 159th of 163 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.8% | 83.2% | 22.5% | Oman |
| 2010s | 64.8% | 79.2% | 14.3% | Oman |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Latvia or Oman?
- Latvia, at 0.0% against 0.0% in Oman as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Latvia and Oman?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Oman?
- 11 years are reported by both, from 2006 to 2022.
- How do Latvia and Oman rank globally for treatment success rate for patients treated for mdr-tb?
- Latvia ranks 159th and Oman ranks 159th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.